These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Psychosis caused by isoniazid]. LEHMANN-GRUBE F Tuberkulosearzt; 1956 Mar; 10(3):160-9. PubMed ID: 13324974 [No Abstract] [Full Text] [Related]
23. Abnormal psychic manifestations during isoniazid therapy for adaptative disease. BARNARD RD Med Times; 1953 Feb; 81(2):104-9. PubMed ID: 13036596 [No Abstract] [Full Text] [Related]
24. Toxic effects of iproniazid in a patient with angina. PAPP C; BENAIM S Br Med J; 1958 Nov; 2(5104):1070-2. PubMed ID: 13584852 [No Abstract] [Full Text] [Related]
25. [Action of vitamin B1 on the convulsions due to isonicotinyl hydrazide]. FLORIS E; MURTAS L Rass Med Sarda; 1953; 55(1-2):59-61. PubMed ID: 13100728 [No Abstract] [Full Text] [Related]
26. Pathological findings in jaundice associated with iproniazid therapy. POPPER H J Am Med Assoc; 1958 Dec; 168(17):2235-42. PubMed ID: 13610612 [No Abstract] [Full Text] [Related]
27. [Three cases of psychosis during isonicotinic acid hydrazide therapy]. TESSING-ERICSSON G Sven Lakartidn; 1953 Apr; 50(15):803-10. PubMed ID: 13077286 [No Abstract] [Full Text] [Related]
28. [Cases of Cushing syndrome in relationship to antituberculotic therapy]. BIKICH G; BORSAY J; PAPP A Tuberk Kerdesei; 1956 Feb; 9(1):22-3. PubMed ID: 13324991 [No Abstract] [Full Text] [Related]
29. Fatal jaundice associated with iproniazid (marsilid) therapy: report of a case. FRANTZ AG J Am Med Assoc; 1958 Jun; 167(8):987-8. PubMed ID: 13549217 [No Abstract] [Full Text] [Related]
30. [Werlhof's disease in isonicotinic acid hydrazide therapy]. MUELLER HC Z Tuberk; 1955; 106(4-5):266-7. PubMed ID: 13300650 [No Abstract] [Full Text] [Related]
31. Peripheral neuritis following isoniazid therapy; appearance of Dupuytren's contracture and Raynaud's phenomenon. HINES RA J Am Med Assoc; 1955 Nov; 159(12):1197-8. PubMed ID: 13263169 [No Abstract] [Full Text] [Related]
32. [Note on circulatory disorders caused by administration of isonicotinic acid hydrazide]. LEIDENBERGER W Tuberkulosearzt; 1953 Mar; 7(3):141-2. PubMed ID: 13077778 [No Abstract] [Full Text] [Related]
33. [Therapeutic use of isonicotinic acid hydrazide and its side-effects]. FICKEL G Dtsch Gesundheitsw; 1953 Apr; 8(18):544-6. PubMed ID: 13067803 [No Abstract] [Full Text] [Related]
34. Peripheral neuritis due to hydrazide derivatives. KATZ S; GRUVER R; SMITH B; McCORMICK G Dis Chest; 1954 Sep; 26(3):264-7. PubMed ID: 13191259 [No Abstract] [Full Text] [Related]
35. [Incidents and complications of isoniazid therapy]. GASCARD E Mars Med; 1956; 93(4):337-44. PubMed ID: 13347339 [No Abstract] [Full Text] [Related]
36. [Ascending radiculomyelitis after neoteben treatment]. SEIBOLD M Med Monatsschr; 1954 Sep; 8(9):622-4. PubMed ID: 13223462 [No Abstract] [Full Text] [Related]
37. [Latency period of the sensitivity to the convulsive effect of isoniazid in the dog and ape after intravenous administration]. PERITI P; BUFFONI NARDINI F Boll Soc Ital Biol Sper; 1953 Mar; 29(3):352-5. PubMed ID: 13081857 [No Abstract] [Full Text] [Related]
38. [Death after 15 grams of isonicotinic acid hydrazide; short communication]. SCHEIBE FW Z Gesamte Inn Med; 1953 Mar; 8(6):283-4. PubMed ID: 13078888 [No Abstract] [Full Text] [Related]
40. [Isoniazid concentration in the cerebrospinal fluid of the ape and dog after intravenous administration, and relation to its convulsant effect]. PERITI P; BUFFONI NARDINI F Boll Soc Ital Biol Sper; 1953 Mar; 29(3):350-2. PubMed ID: 13081856 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]